Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-11

In terms of asx listed cannabis drug mdc is the leader and closest to registered medicine. Has been listed since 2015. I think deb is a little miffed his out on CAN is doing so badly and missed the boat on cau. I remember when cau was sold down from 30c to 7c range would have felt bad for investors but now up near 1$ and paying a dividend. CAN is in big trouble with the heaviest debt I have seen.. $50million in debt. So MDC is a better position for a much cheaper price too. But if they want to continue selling down MDC to half value of MXC joke of a company with 900k$ in bank then I will happily buy if they keep selling it down further. But atm I will steer clear and hold onto CAU.

Cheer up deb.